Pulmonx Corporation (LUNG)
USD 5.72
(-13.33%)
USD 5.72
(-13.33%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 178.95 Million USD | -7.6% |
| 2022 | 193.67 Million USD | -17.65% |
| 2021 | 235.17 Million USD | -10.82% |
| 2020 | 263.7 Million USD | 392.61% |
| 2019 | 53.53 Million USD | 256.58% |
| 2018 | 15.01 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 172.62 Million USD | 4.89% |
| 2024 Q3 | 167.4 Million USD | -3.03% |
| 2024 Q1 | 164.58 Million USD | -8.03% |
| 2023 Q3 | 185.01 Million USD | -4.19% |
| 2023 FY | 178.95 Million USD | -7.6% |
| 2023 Q4 | 178.95 Million USD | -3.28% |
| 2023 Q2 | 193.11 Million USD | -4.05% |
| 2023 Q1 | 201.27 Million USD | 3.92% |
| 2022 Q4 | 193.67 Million USD | -4.22% |
| 2022 Q3 | 202.2 Million USD | -4.95% |
| 2022 FY | 193.67 Million USD | -17.65% |
| 2022 Q2 | 212.72 Million USD | -4.54% |
| 2022 Q1 | 222.84 Million USD | -5.24% |
| 2021 Q1 | 255.27 Million USD | -3.2% |
| 2021 FY | 235.17 Million USD | -10.82% |
| 2021 Q2 | 248.94 Million USD | -2.48% |
| 2021 Q4 | 235.17 Million USD | -4.72% |
| 2021 Q3 | 246.81 Million USD | -0.85% |
| 2020 Q4 | 263.7 Million USD | 270.15% |
| 2020 Q2 | 66.72 Million USD | 0.0% |
| 2020 Q3 | 71.24 Million USD | 6.78% |
| 2020 Q1 | - USD | -100.0% |
| 2020 FY | 263.7 Million USD | 392.61% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 53.53 Million USD | 256.58% |
| 2019 Q4 | 53.53 Million USD | 0.0% |
| 2018 FY | 15.01 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Envoy Medical, Inc. | 7.64 Million USD | -2242.291% |
| OrthoPediatrics Corp. | 449.58 Million USD | 60.196% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -556.219% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 18.156% |
| Nexalin Technology, Inc. | 3.63 Million USD | -4827.179% |
| PAVmed Inc | 33.11 Million USD | -440.327% |
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -470.525% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -24.746% |
| RxSight, Inc. | 182.55 Million USD | 1.972% |
| Sight Sciences, Inc. | 166.65 Million USD | -7.381% |
| SI-BONE, Inc. | 230.42 Million USD | 22.339% |
| TELA Bio, Inc. | 78.04 Million USD | -129.283% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 28.961% |
| Bioventus Inc. | 810.91 Million USD | 77.932% |
| BrainsWay Ltd. | 62.97 Million USD | -184.176% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -1567.763% |
| CVRx, Inc. | 115.22 Million USD | -55.3% |
| electroCore, Inc. | 16.38 Million USD | -992.03% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -2226.456% |
| Inogen, Inc. | 326.19 Million USD | 45.14% |
| IceCure Medical Ltd | 16.41 Million USD | -990.5% |
| Spectral AI, Inc. | 10.69 Million USD | -1573.691% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -979.383% |
| MaxCyte, Inc. | 268.27 Million USD | 33.295% |
| Acutus Medical, Inc. | 53.96 Million USD | -231.636% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -5644.349% |
| Talis Biomedical Corporation | 98.34 Million USD | -81.972% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -2110.004% |
| Orthofix Medical Inc. | 925.31 Million USD | 80.661% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -205.06% |
| Cerus Corporation | 197.74 Million USD | 9.506% |
| Venus Concept Inc. | 93.65 Million USD | -91.077% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -595.631% |
| LivaNova PLC | 2.42 Billion USD | 92.634% |
| 908 Devices Inc. | 202.98 Million USD | 11.839% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 77.776% |
| Nemaura Medical Inc. | 14.56 Million USD | -1128.786% |
| NeuroPace, Inc. | 107.65 Million USD | -66.233% |
| LENSAR, Inc. | 69.58 Million USD | -157.169% |
| Apyx Medical Corporation | 79.24 Million USD | -125.834% |
| Cutera, Inc. | 346.29 Million USD | 48.324% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -325.912% |
| BioSig Technologies, Inc. | 1.79 Million USD | -9852.781% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 33.877% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -319.472% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 95.268% |
| Axonics, Inc. | 719.92 Million USD | 75.143% |
| Outset Medical, Inc. | 313.8 Million USD | 42.973% |
| IRIDEX Corporation | 34.43 Million USD | -419.663% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 55.784% |
| IRadimed Corporation | 92.15 Million USD | -94.182% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -3305.995% |
| INVO Bioscience, Inc. | 20.88 Million USD | -756.726% |
| Telesis Bio, Inc. | 70.41 Million USD | -154.152% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -16.125% |
| Varex Imaging Corporation | 1.24 Billion USD | 85.679% |
| Quipt Home Medical Corp. | 247.4 Million USD | 27.67% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -1822.137% |
| Dynatronics Corporation | 25.94 Million USD | -589.85% |
| Modular Medical, Inc. | 13.8 Million USD | -1196.089% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -1568.23% |
| Semler Scientific, Inc. | 78.06 Million USD | -129.233% |
| InMode Ltd. | 863.28 Million USD | 79.271% |
| Bruker Corporation | 4.24 Billion USD | 95.789% |
| Cytosorbents Corporation | 53.26 Million USD | -235.991% |
| DexCom, Inc. | 6.26 Billion USD | 97.143% |
| Align Technology, Inc. | 6.08 Billion USD | 97.059% |
| Viveve Medical, Inc. | 25.91 Million USD | -590.584% |
| ZimVie Inc. | 1.2 Billion USD | 85.154% |
| Movano Inc. | 9.42 Million USD | -1799.49% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 64.042% |
| Nexalin Technology, Inc. | 3.63 Million USD | -4827.179% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -205.06% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 81.216% |
| Profound Medical Corp. | 43.68 Million USD | -309.627% |
| Insulet Corporation | 2.58 Billion USD | 93.086% |
| enVVeno Medical Corporation | 48.63 Million USD | -267.947% |
| Surmodics, Inc. | 185.73 Million USD | 3.651% |
| iCAD, Inc. | 41.41 Million USD | -332.061% |
| Nuwellis, Inc. | 9.77 Million USD | -1731.638% |
| Biotricity, Inc. | 5.94 Million USD | -2911.312% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 58.686% |
| Aethlon Medical, Inc. | 8.24 Million USD | -2070.16% |
| InspireMD, Inc. | 47.64 Million USD | -275.608% |
| PAVmed Inc. | 33.11 Million USD | -440.327% |
| BIOLASE, Inc. | 35.1 Million USD | -409.817% |
| Beyond Air, Inc. | 56.96 Million USD | -214.164% |
| FONAR Corporation | 214.24 Million USD | 16.474% |
| AxoGen, Inc. | 196.82 Million USD | 9.082% |
| Vivani Medical, Inc. | 45.79 Million USD | -290.748% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 36.415% |
| Inari Medical, Inc. | 674.23 Million USD | 73.459% |
| UFP Technologies, Inc. | 404.13 Million USD | 55.72% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -664.795% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -1783.078% |
| Tenon Medical, Inc. | 6.34 Million USD | -2720.347% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -1802.317% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -72.653% |
| AdaptHealth Corp. | 4.61 Billion USD | 96.126% |
| Sintx Technologies, Inc. | 15.36 Million USD | -1064.666% |
| NanoVibronix, Inc. | 6.67 Million USD | -2581.316% |
| Quanterix Corporation | 425.01 Million USD | 57.895% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -1822.137% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -233.075% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 89.751% |
| TransMedics Group, Inc. | 706.04 Million USD | 74.655% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -183.186% |
| NeuroMetrix, Inc. | 21.42 Million USD | -735.266% |
| Hyperfine, Inc. | 94.19 Million USD | -89.971% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 33.387% |
| Biomerica, Inc. | 9.25 Million USD | -1833.769% |
| Bone Biologics Corporation | 3.73 Million USD | -4687.65% |
| AVITA Medical, Inc. | 144.33 Million USD | -23.979% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -3575.667% |
| Silk Road Medical, Inc | 265.3 Million USD | 32.55% |